Market Research Blog – Page 1493 – New Product Development

FMI Analysis Affirms Global Driver Monitoring System Market Valuation to Cross USD 9.3 Billion Mark by 2033, Driving 7.5% CAGR Growth

The driver monitoring system (DMS) market is projected to grow at a steady compound annual growth rate (CAGR) of 7.5% from 2023 to 2033. The market is expected to reach a valuation of USD 9.3 billion by 2033, up from USD 4.5 billion in 2023.

The increasing demand for self-driving and semi-autonomous vehicles, including both passenger and commercial vehicles, is driving the adoption of driver monitoring system technologies. These systems utilize advanced technologies such as high-end cameras, infrared sensors, lasers, and sophisticated sensors to enhance vehicle safety.

Improvements in road infrastructure and updated road safety regulations, particularly in relation to electric and autonomous vehicles, are anticipated to positively impact the market. Additionally, the integration of advanced technologies like artificial intelligence (AI) and advanced driver-assistance systems (ADAS) is contributing to the growing adoption of driver monitoring systems.

New startups are entering the market with innovative solutions such as alarm systems and smartphone integration, which provide custom alerts to drivers and their contacts. The recovery of logistics and tourism sectors post-COVID-19 is also fueling market growth.

The increasing number of accidents caused by driver distraction and drowsiness is prompting authorities to implement regulations mandating the use of driver monitoring systems and other safety features in vehicles. For instance, European safety organizations like Euro NCAP are pursuing ambitious goals such as Vision Zero, aiming to eliminate road accidents and further boost the demand for driver monitoring systems.

Key Takeaways from the Driver Monitoring System Market Report:

The United States market leads the driver monitoring system market in terms of market share in North America. The United States region holds a market share of 16.9% in 2023. The growth in this region is attributed to the presence of major autonomous vehicle vendors along with government policies pushing end users to adopt the technologies.
In 2022, the United States market held a market share of 87.5% in North America, putting it as a leading region in terms of market share.
The United Kingdom’s driver monitoring system market is another significant market in the European region. The market thrives at a CAGR of 5.2% between 2023 and 2033. The growth is attributed to the advanced European NCAP policies.
The Chinese driver monitoring system market thrives at a CAGR of 11.8% during the forecast period. The growth is attributed to higher autonomous vehicle production and stringent safety rules.
The ultrasonic sensors lead the technology type segment as it holds a market share of 20.5% in 2023. The growth is attributed to the higher affordability and its enhanced accuracy in the dark.
Based on the vehicle type, the light commercial vehicle segment leads as it holds a market share of 26.0% in 2023.

Competitive Landscape:

The key vendors work on adding the latest safety technologies including infrared and laser sensory technology. Key competitors and also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

Leading Key Players:

Continental AG
ZF Friedrichshafen AG
Mobileye
Aptiv Plc
Veoneer Inc.
Valeo SA
Magna International
Aisin Seiki Co., Ltd
Texas Instruments Incorporated
NXP Semiconductors N.V
Renesas Electronics Corporation
Intel Corporation
Hitachi, Ltd.

Driver Monitoring System Market Segmentation:

By Technology:

Ultrasonic Sensor
Lidar Sensor
Radar Sensor
Camera Sensor
Infrared Sensor
Pressure Sensor

By Sales Channel:

OEM
Aftermarket

By Vehicle Type:

Passenger Vehicle
Light Commercial Vehicle
Heavy Commercial Vehicle

Key Regions Covered:

North America
- UNITED STATES
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Europe
- Germany
- United Kingdom
- France
- Spain
- Russia
- Rest of Europe
Japan
APEJ
- China
- India
- Malaysia
- Singapore
- Australia
- Rest of Asia Pacific Excluding Japan (APEJ)
MEA
- GCC Countries
- Israel
- South Africa
- Rest of Middle East Asia (MEA)

Access Report Details for More In-Depth Information:

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Automated Material Handling Systems Market Size to Reach USD 81.8 Billion Mark by 2033, Surging at 9.2% CAGR Growth

The global automated material handling systems market is anticipated to grow at a CAGR of 9.2% over the course of the forecast period, according to the most recent study by FMI. The market is anticipated to be worth USD 34 billion in 2023. The value is expected to hit USD 81.8 billion by 2033.

The global industry for these machines is growing rapidly in part because they offer increased efficiency and lower labor costs when compared with traditional methods of transporting goods around warehouses or plant floors.

The material handling industry is expected to benefit from the growing trend toward smart factories. In order to evaluate operating efficiency and decrease waste, the entire manufacturing floor now requires monitoring at every step of the process. In such cases, smart factories with handling equipment provide continuous monitoring of all processes. Furthermore, many intuitive technologies included in material handling systems, such as cloud connectivity and data analytics, improve asset performance and give real-time actionable data.

Wireless remote-control systems that help give better diagnostics and save commissioning time are also provided by the incorporation of such automated material systems placed in facilities. The rise of Industry 4.0 and smart factory development is creating a potential market for automated material handling systems as a result of the aforementioned considerations.

The failure or breakdown of AMH equipment can have a significant impact on a company’s overall earnings. Breakdowns cause the entire production process to be delayed, resulting in output losses and plant performance degradation. As a result, such automated material handling systems businesses must invest extensively in preventive maintenance of their AMH equipment in order to avoid downtime and assure proper operation.

Key Takeaways From The Market Study:

Due to factors such as the rising need for industrial processes and warehousing units, Asia Pacific dominates the worldwide automated material handling systems market.
Due to increased penetration of online shopping trends, the presence of large online vendors, rising logistics infrastructure, and other factors, the e-commerce sub-segment is predicted to grow significantly throughout the projection period. This trend is driving warehouse operators to add automation technology into their warehouses in order to manage the supply chain ecosystem more efficiently.
The unit load sub-segment is predicted to grow at the fastest rate, propelling the automated material handling systems market forward in the near future. This can be attributed to the e-commerce industry’s expansion.
Due to rising consumption from the food and beverage, pharmaceutical, and e-commerce industries, the packaging sub-segment is predicted to rise gradually over the projected timeline.

Competitive Landscape:

Due to the growing demand for increased efficiencies at distribution centers as a result of the expansion of e-commerce, prominent corporations are proactively working on supplying automated material handling systems for logistics solutions businesses. Furthermore, to supplement the market for handling equipment, these main companies are focusing on sales efforts. According to secondary sources, European retailers ordered Vanderlande TMHE’s AGFs to establish a fully automated distribution center in their new distribution facility.

Dominant Players in the Market:

Daifuku
KION
SSI Schaefer
Toyota Industries
Honeywell International is among the key players.

Recent Developments:

KION Group will open a new forklift truck manufacturing in China in December 2021 to provide supply chain solutions. For future manufacture of industrial trucks and supply chain solutions in Jinan, the plant has a total volume of roughly 140 million.
Toyota Material Handling Japan introduced the SenS+ operation system in August 2021, which detects and identifies pedestrians and objects behind the forklift and instantly controls and stops the truck’s backward motion.
Daifuku and AFT industries collaborated in February 2021 to combine their material handling capabilities in the automotive business. Daifuku and AFT will benefit from each other as a strategy to open global markets and secure increased demand and investments in material handling systems from car manufacturers.

Key Segments Covered:

By Product:

Robots
ASRS
Conveyors & Sortation Systems
Cranes
WMS
AGV

By System Type:

Unit Load Material Handling
Bulk Load Material Handling

By Vertical:

Automotive
Metals & Heavy Machinery
Food & Beverages
Chemicals
Healthcare
3PL
Semiconductors & Electronics
Aviation
E-Commerce
Others

By Region:

North America
Europe
Latin America
Asia Pacific
Middle East and Africa

Access Report Details for More In-Depth Information:

Author:

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Global Keloid Treatment Market Poised for Growth, Expected to Reach USD 5.6 Billion by 2033 at a 3.8% of CAGR

Global Keloid Treatment Industry — Global Keloid Treatment Market

The global keloid treatment market has demonstrated significant growth, reaching a valuation of USD 3.8 billion in 2023. With the increasing prevalence of keloids worldwide, the market is projected to expand substantially, achieving a forecasted value of USD 5.6 billion by the end of 2033. The market is set to grow at a compound annual growth rate (CAGR) of 3.8% from 2023 to 2033.

Keloids, characterized by the abnormal growth of scar tissue, have become a widespread concern globally. The escalating incidence of keloids has generated an increasing demand for effective treatment solutions. This surge is not only attributed to the rising prevalence of keloids but also to the continuous advancements in medical technologies and increased awareness among individuals seeking optimal solutions for scar management.

Global Keloid Treatment Industry: Dynamics

The Global Keloid Treatment Industry growth is substantially driven by the rising prevalence of keloid scars as well as the development of multiple keloids. A growing consciousness among patients regarding their appearance is also driving the market of keloid treatment as keloid scars on the exposed body parts lead to ugly appearances. Other factors that are driving the growth in the keloid treatment market include increasing reimbursement for keloid therapies, formalization of standard treatment guidelines for keloid and increasing use of combination therapies. Clinics and hospitals are focussing on the adoption of advanced therapy options. CryoShape is used to reduce the impact of keloid scar and recurrence rate. Sensus Healthcare has developed an advanced superficial radiation therapy device to impart better treatment with limited adverse reactions.

Keloid Treatment Market: Segmental Forecast

The Global Keloid Treatment Industry is segmented based on treatment type, end user and region. The market has been segmented based on treatment type into occlusive dressing, compression therapy, cryosurgery, excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injection, and others. Other treatment options include dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod. The intralesional corticosteroid injection treatment segment dominates the Global Keloid Treatment Industry as this procedure is considered the gold standard and is being used in combination with other therapies. Intralesional corticosteroid injection is expected to be the second most lucrative segment by treatment type, with a market attractiveness index of 2.1 during the forecast period.

Based on end users, the Global Keloid Treatment Industry is segmented into hospitals, dermatology clinics, ambulatory surgical centres and others. The hospital segment is expected to remain dominant, as most of the radiation therapies and excision procedures are performed in hospitals. Hospitals are the largest segment by the end-user, which is estimated to represent US$ 1,164.7 Mn, or 37.0% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,643.8 Mn, or 37.2% share of the total market by the end of 2027, expanding at a CAGR of 3.5% in terms of value.

Keloid Treatment Industry: Regional Analysis

Based on region, the Global Keloid Treatment Industry is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East & Africa.

North America dominated the Global Keloid Treatment Industry in 2016 and is expected to continue to dominate the global market throughout the forecast period. North America is the largest region in the keloid treatment market, which is estimated to represent US$ 1,105.6 Mn, or 35.1% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,549.6 Mn, or 35.1% of the total market by the end of 2027, expanding at CAGR of 3.4% in terms of value. Clinics in North America are opting for advanced treatment therapies that can aid in reducing the risk of recurrence.

Keloid Treatment Market: Vendor Analysis

Leading players in the Global Keloid Treatment Industry are launching new portable and mobile radiation therapy devices and offering patients better treatment options. Companies are targeting dermatology clinics to market their devices, where patients are provided the first line of treatment for keloid. Some of the players operating in the Global Keloid Treatment Industry who have been profiled in the report include Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.

Segmentation The Keloid Treatment Market is segmented as follows:

Keloid treatment industry, by treatment type
Keloid treatment industry, by end-user
Keloid treatment industry, by region

The keloid treatment industry report begins with an overview of keloid treatment and key market definitions. This section also underlines factors influencing revenue growth of the Global Keloid Treatment Industry along with a detailing of the key trends, drivers, restraints, and opportunities. The next section of the report analyses the market based on treatment type and presents the forecast in terms of value for the next 10 years.

Treatment types covered in the report include:

Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others

The subsequent section covers the market analysis based on end-users and presents the forecast in terms of value for the next 10 years. End users considered in the report include:

Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Handheld Ultrasound Scanner Market Expected to Reach USD 750.3 Million by 2034 at a 3.90% of CAGR

The global handheld ultrasound scanner market is on a promising growth path, with an estimated value of USD 511.8 million in 2024. According to recent forecasts, the market is anticipated to reach USD 750.3 million by 2034, recording a Compound Annual Growth Rate (CAGR) of 3.90% over the forecast period.

The growth of the handheld ultrasound scanner market is driven by the increasing demand for portable and cost-effective diagnostic imaging solutions. Handheld ultrasound scanners are gaining popularity due to their convenience, ease of use, and ability to provide real-time imaging at the point of care.

Technological developments have resulted in the development of portable ultrasound scanners that are easy to use and can be coupled via Bluetooth or Wi-Fi with smartphones or tablets. Smooth photo transmission to medical institutions is made possible by these features, which also improve user-friendliness and expedite treatment planning and diagnostics.

Global Handheld Ultrasound Scanners Market: Dynamics

The global market for handheld ultrasound scanners is growing due to a number of factors, including technological advancements in medical imaging devices, an increase in non-radiologist use of these devices, the benefits of international trade agreements, an increase in the import of imaging diagnostics systems, an increase in healthcare expenditures, a rise in the number of medical device manufacturers, an increased focus on inorganic growth by healthcare companies, innovations and developments in ultrasound scanning technology, modernization of healthcare investment, changing healthcare patterns, an increase in the prevalence of chronic disorders, and the adoption of distribution and licensing agreements by various players to increase product penetration. However, there are limitations due to things like non-standardized product pricing, growing consumption taxes, a shortage of qualified specialists, a lack of research and development in some fields, and medical device counterfeiting to the growth of the global handheld ultrasound scanners market.

Global Handheld Ultrasound Scanners Market: Segmental Highlights

The global handheld ultrasound scanners market is segmented by end user (hospitals, diagnostic centres, ASCs and others), modality type (wired scanners and wireless scanners), display type (black and white display and colour display) and region (North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East and Africa).

In 2021, the North America handheld ultrasound scanners market was dominated by the US, which held a share of approximately 86.6%. Over the forecast period, the U.S. market is expected to experience a stable growth rate of 10.2%, which is considered lucrative. Despite the fact that the majority of maternal deaths in the U.S. could be prevented, they have been increasing since 2000.
The global handheld ultrasound scanners market was predominantly led by wired modalities in 2021, accounting for a share of approximately 83.6%. According to FMI’s projections, this segment is expected to continue its growth trajectory with a steady CAGR of about 8.6% throughout the forecast period.
In 2021, colored display held the majority of revenue share in the global handheld ultrasound scanners market at 60.4%. The segment is expected to experience gradual growth with a CAGR of 10.0% throughout the evaluation period. Colored display ultrasound scanners are known for their ability to capture images with accuracy and precision, which may contribute to their popularity and continued growth in the market.
The hospital segment accounted for a significant revenue share of 37.2% in the handheld ultrasound scanners market in 2021. Going forward, the segment is expected to continue its growth trajectory with a gradual CAGR of 9.9% during the forecast period. This can be attributed to the increasing demand for handheld ultrasound scanners in hospitals, which can provide healthcare professionals with real-time images for diagnosis and monitoring purposes.

Global Handheld Ultrasound Scanners Market: Competition Analysis

The global handheld ultrasound scanners market research report includes company profiles of key players involved in the daily operations of handheld ultrasound scanners. Koninklijke Philips N.V., GE Healthcare, Fujifilm SonoSite, Inc., Clarius Mobile Health, Signostics Limited, Sonoscanner SARL, Mobisante, Inc., Terason (Teratech corp.), Shenzhen Sunway Medical Device Co., Ltd., Shenzhen WELLD Medical Electronics Co., Ltd., Shenzhen Landwind Industry Co., Ltd., Healcerion, Co., Ltd., Meditech Equipment Co.,Ltd (Meditech Group), Sino-Hero(Shenzhen) Bio-Medical Electronics Co., Ltd., Caresono Technology CO., Ltd., Sonostar Technologies Co., Ltd., DGH Technology, Inc., and Xuzhou Palmary Electronics Co., Ltd., are the key players analysed in the global handheld ultrasound scanners market research study.

A Old Full Report Analysis Click Here

Key Segments Covered in Handheld Ultrasound Scanners Market Report

By Modality:

Wired
Wireless

By Display:

Black & White Display
Color Display

By End User:

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Others

About Future Market Insights (FMI)

Contact Us:

Pharmacy Automation Market Set to Soar, Projected to Reach USD 12,136.3 Million by 2034 at a 8% of CAGR

As automation continues to transform various sectors globally, the pharmacy industry is witnessing a significant shift towards automated systems designed to enhance precision and efficiency. The pharmacy automation system market, valued at approximately USD 5,621.5 million in 2024, is poised for substantial growth, with projections indicating it will surpass USD 12,136.3 million by 2034.

These systems are used by both inpatient and outpatient pharmacies. Pharmacy automation systems also include properties like the ability to measure personalized medications, track and update consumers’ information in a database, and monitor the all-over procedure of inventory management and distribution. Consequently, they are a suitable replacement for manual dispensing across drugstores. The installation of these systems has immensely improved the efficiency and security of storing, administering, filling, packaging, and labeling prescription medications. These considerations, coupled with other factors like the introduction of cost-effective automation solutions, incorporation of advancing technology into the target product, etc., are likely to drive the growth of the pharmacy automation systems market during the forecast period.

Furthermore, the rising awareness of the benefits of pharmacy automation technologies is encouraging many small and mid-sized healthcare hospitals and retail pharmacies to replace their traditional pharmacy operation practices with these systems. This will boost the market prospects during the next decade.

“Rising awareness of the advantages of pharmacy automation systems along with favorable government policies will supplement the global growth of the pharmacy automation systems market over the forecast period,” says an FMI analyst.

Key Takeaways:

By end user, the hospital pharmacies segment will grow at a high CAGR over the forecast period.
On the basis of application, drug dispensing and packaging will continue to dominate the global market growth.
Accounting for 42.6% of the market share in 2021, the medication dispensing cabinets will present a steady growth over the assessment period.
Germany’s pharmacy automation systems market will register a 7.9% CAGR.
The pharmacy automation systems market in the U.S. will acquire a 56.6% share of the global market.
Increasing number of pharmacies drives the target market growth in India.

Competitive Landscape

AmerisourceBergen Corporation, Baxter International Inc., Swisslog Holdings AG, Care Fusion Corporation, Cerner Corporation, Kirby Lester LLC, Talyst, LLC., Omnicell Inc., and ScriptPro LLC among others are some of the major players in the pharmacy automation systems market profiled in the full version of the report.

Key market players are keen on adopting tactics such as new product releases and increasing investments in research and development. These organizations are also focusing on employing mergers, acquisitions, partnerships, and collaboration strategies to expand their consumer base.

More Insights into Pharmacy Automation Systems Market Report

In its latest report, FMI offers an unbiased analysis of the global pharmacy automation systems market, providing historical data from 2014 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (robotic dispensing machines, carousel storage, tablet splitters), application (drug dispensing & packaging, drug storage, inventory management), end user (hospital pharmacies, clinic pharmacies, retail pharmacies, mail order pharmacies, pharmaceutical SME’s), and region.

According to the latest FMI reports, based on segmentation, the medication dispensing cabinets segment will demonstrate steady growth owing to its higher rate of adoption. The drug dispensing and packaging segment held 47% of the market share in 2021 and will likely retain its lead while the hospital pharmacies segment is anticipated to register a high CAGR during the projection period.

Based on region, the pharmacy automation systems market in Germany is projected to exhibit substantial growth, recording a positive CAGR of 7.9% during 2022-2032. A well-established and advancing healthcare sector, a rising geriatric population, growing concerns regarding improper inventory management, and the high cost of storing inventory are certain considerations that drive the growth of the target market in this country. Germany accounted for 3.3% of the global pharmacy automation systems market share in the year 2021. Other countries like India and the United States are predicted to present impressive growth in the pharmacy automation systems market over the forecast period.

A Old Full Report Analysis Click Here

Key Market Segments Covered in Pharmacy Automation Systems Industry Research

By Product:

Medication Dispensing Cabinets
Packaging & Labelling Machines
IV Pharmacy
Robotic Dispensing Machines
Carousel Storage
Tablet Splitters

By Application:

Drug Dispensing & Packaging
Drug Storage
Inventory Management

By End User:

Hospital Pharmacies
Clinic Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Pharmaceutical SME’s

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vascular Closure Devices Market Poised for Significant Growth, Expected to Reach USD 2,466.5 Million by 2033 at a 5.30% of CAGR

Global Vascular Closure Devices Industry — Global Vascular Closure Devices Market

The vascular closure devices market is experiencing notable growth and evolution, with a market valuation of approximately USD 1,468.4 million in 2023. The market is projected to reach an impressive USD 2,466.5 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.30% over the forecast period from 2023 to 2033.

North America to Exhibit Steadfast Adoption of Vascular Closure Devices

A regional analysis provided in the report reveals North America as the largest market for vascular closure devices. The region is anticipated to remain at the forefront of the global expansion of the vascular closure devices market through 2022. Robust healthcare marketplaces in the US, coupled with consumer lifestyles that have surged the incidence of cardiac disorders, will continue to boost North America’s presence in the global vascular closure devices market. The report also projects that the Asia-Pacific excluding Japan (APEJ) region will register the fastest growth in its vascular closure devices market, and rake over US$ 145 million by the end of 2022.

Clip-based VCDs to Register 6% CAGR through 2022

A key insight from the report reveals that the demand for clip-based vascular closure devices will be relatively higher than for compression devices and haemostasis pads. Despite the latter being top-selling products in the global vascular closure devices market, clip-based VCDs are expected to outpace them in terms of demand over the next five years. From a medical standpoint, many surgeons prefer VCDs designed with active approximators that can physically close the arteriotomy by using nitinol clips. These metallic clips can also restrict MRI scanners from capturing the unnecessary structures which are immediately adjacent to the arteriotomy. These clip-based VCDs can boost procedural efficiency as well as post-procedural diagnostics for a wide range of cardiovascular treatments.

Companies to Watch

Companies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market. Shortly, several manufacturers of vascular closure devices will be focusing on reducing the existing drawbacks of using VCDs, which include extended hospitalisation, high morbidity risks, and the need for administering antibiotics. Some companies will also be focusing on advancing their umbrella on VCD technologies and improving the quality of life for patients being treated through vascular closure devices.

A Old Full Report Analysis Click Here

Vascular Closure Devices Market Taxonomy

The taxonomy of the global vascular closure device market has been concisely illustrated in the table below:

Region

North America
Latin America
Europe
Japan
APEX
META

Product Type

Haemostasis Pads
Compression Devices
Clip
Plug
Suture
Others

End User

Hospitals
Ambulatory Surgical Centres
Independent Catheterisation Labs

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Ambulatory Surgical Centers Market Poised for Growth, Projected to Reach USD 150.6 Billion by 2033 at a 4.5% of CAGR

The global ambulatory surgical centers market is on a promising growth trajectory, with a valuation of USD 96.5 billion in 2023. The market is projected to expand significantly, reaching USD 150.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.5% over the forecast period.

The ASCs offer adequate treatments to cure illnesses, along with providing many facilities including reimbursement policies and insurance options. Thus, providing a cost-effective treatment to patients, lower than the expenses incurred at hospitals.

At ASCs, physicians are in a better position to control expenses and patient experience. By concentrating on one specialty and owning the equipment, it becomes easier for healthcare providers to schedule procedures and run an operating room efficiently. Therefore, more physicians are opening up ASCs to cater to the growing demand for surgical procedures. Going forward, the ambulatory surgical centers market is being governed by the research and development activities initiated by key players for the advancement of the market.

Key Takeaways from the Ambulatory Surgical Centers Market:

The U.S. market is predicted to maintain its prominent position over the forecast period as well, and reach US$ 73.5 billion by 2033. The market is predicted to record a CAGR of 4.5% from 2023 to 2033.
In Asia Pacific, Japan is estimated to attain US$ 5.7 billion by 2033. The market valuation of Japan is significant than China, which attained US$ 5.3 billion in the same year.
However, the growth of the market in China is projected to be 5% CAGR, greater than the 2.4% CAGR estimated for the market in Japan.
Over the forecast period, the surgical services segment is projected to emerge as the leading service, recording a CAGR of 4.6%.The
Increasing number of ASCs delivering high-quality outpatient surgical care is projected to contribute towards the progress of this segment.

News Featuring Market Developments by Key Players of Ambulatory Surgical Centers:

In January 2023, Hudson Medical Center, a US$50 million and 1, 60,000 square foot facility, opened its gates for patients. At the same premises, the first ASC in St. Croix County, named Valley Surgery Center, will also be present. The center will be able to operate about 10,000 surgeries every year, after its commencement.
In August 2022, HCA Healthcare, a major healthcare provider in the U.S., announced its acquisition of Stone Oak Surgery Center, in association with 11 physician partners. The latter is a San Antonio-based ASC, authorized by the Centers for Medicare & Medicaid Services (CMS), and offers multispecialty services. With this acquisition, HCA Healthcare will extend its footprint in San Antonio.
Earlier, in January 2022, the company had revealed its decision to develop five new hospitals, offering all the necessary services in Texas. With this initiative, the company aims to cater to the rising need for healthcare services in the state.

Key Companies Profiled:

AmSurg Corp
Tenet Healthcare
HCA Holdings, Inc.
Surgical Care Affiliates, Inc.
Surgery Partners
Ambulatory Surgical Centers of America
Pinnacle III
Proliance Surgeons
Regent Surgical Health
SurgCenter Development

A Old Full Report Analysis Click Here

Ambulatory Surgical Centers Market by Category

By Centers Type:

Single Specialty Centers
MultiSpecialty Centers

By Modality:

Hospital-Based Ambulatory Surgical Center
Freestanding Ambulatory Surgical Center

By Services:

Diagnostic Services
Surgical Services

By Specialty Area:

Gastroenterology
Ophthalmology
Orthopedics
Pain/Neurology
Urology
Dermatology
Others

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Vital Signs Monitoring Devices Market Set to Surge, Projected to Exceed USD 16 Billion by 2033 at a 8% of CAGR

Global Vital Signs Monitoring Devices Industry — Global Vital Signs Monitoring Devices Market

The global vital signs monitoring devices market is poised for significant growth, with an expected valuation to surpass USD 16 billion by 2033. The market, valued at USD 7.4 billion in 2023, is anticipated to expand at a robust compound annual growth rate (CAGR) of 8% over the forecast period from 2023 to 2033.

The healthcare industry is at the front line of the coronavirus (COVID-19) pandemic. As epidemiological numbers continue to soar, the industry is running out of resources for treating the expanding patient pool. In a bid to ease off the burden, players such as Medtronic Plc. and Masimo Corporation are launching vital signs monitoring devices to treat patients remotely.

Key Takeaways of Vital Signs Monitoring Devices Industry Study

Monitors, followed by temperature measurement devices, account for a larger value share in the global vital signs monitoring devices industry, owing to their increasing use in hospitals and other diagnosis centers for patient monitoring.
Standalone vital signs monitoring devices hold a leading revenue share, owing to their availability and increasing installation rates in hospitals and other healthcare centers.
Hospitals capture around 70% value share in the vital signs monitoring devices industry, owing to high patient preference for diagnosis and treatment of different diseases in these settings.
North America will continue to define stakeholders’ bottom lines in the global vital signs monitoring devices industry during the forecast period.
Upsurge in government funding to increase the number of hospitals and improve quality of care is expected to drive the growth of the vital signs monitoring devices Industry in Asia.

New Product Development and Launch – Imperative Strategy for Market Players

Market introduction of new innovative products as per patients’ needs is majorly responsible for intense competition among players in the vital signs monitoring devices industry. Several companies are focusing on launching customizable vital signs monitoring devices to increase their product sales and expand market share.

For example, in December 2021, Nihon Kohden Corporation launched the life scope SVM-7200 series vital sign monitors – easy-to-use, portable monitors having customizable early warning functionality to help clinicians.

What else is in the report?

Future Market Insights offer a unique perspective and actionable insights on the vital signs monitoring devices industry in its latest study, presenting a historical demand assessment of 2012-2021 and projections for 2022-2030, based on product (monitors, temperature measurement devices, blood pressure measurement devices, and standalone pulse oximeters), mount type (standalone and portable), end user (hospitals, clinics, ambulatory surgical centers, and home care settings), across seven key regions.

The top companies in the market are:

Philips
General Electric Co.
Medtronic

A Old Full Report Analysis Click Here

Vital Signs Monitoring Devices Market Segmentation

By Product Type:

Monitors (Low Utility Monitors, Mid Acuity Monitors, High Acuity Monitors)
Temperature Measurement Devices (Liquid Filled Thermometers, Digital Thermometers, Infrared Thermometers)
Blood Pressure Measurement Devices (Sphygmomanometers, Automated Blood Pressure Monitors)
Standalone Pulse Oximeters

By Mount Type:

Standalone
Portable

By End-user:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Animal Healthcare Market Set for Robust Growth, Projected to Reach USD 62.3 Billion by 2033 at a 4.3% of CAGR

The global animal healthcare market is on a strong upward trajectory, with a projected valuation of USD 40.9 billion in 2023. The market is anticipated to reach USD 62.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period.

Another contributing factor is the growing health consciousness among individuals, leading to increased demand for protein-rich foods like chicken, fish, beef, and meat. The expansion of veterinary hospitals and online and offline distribution channels worldwide is also contributing to the positive market outlook.

Moreover, the development of innovative technological systems that enable vital data generated in veterinary clinics to be uploaded to the Internet and shared with clinicians is driving market growth. Rising R&D activities in the healthcare industry to test the efficacy of drugs and medical devices are also propelling the market.

Finally, the use of animals in drug development for researching several genetic and chronic human diseases is driving market growth further.

Key Takeaways from the Animal Healthcare Market Study

The US is to witness a significant growth of 3.7% due to a wide range of definitive measures that have been adopted by government animal welfare organizations that are consistently working to improve animal health overall.
In recent years, India’s animal health industry has evolved from disease control and treatment activities to a full-service healthcare provider, assisting in the task of bridging the protein gap. It is expected to expand at a rate of 6.2%, compared to the global growth of 4.3%.
Parasiticides show the most substantial growth of 3.2 % among other segments due to the increased number of animal livestock in emerging markets, developments in parasiticide products, and upcoming new offerings by the key players,
Farm animals show a promising growth of 4.3% due to favorable policies. The policies are focused on long-term sustainability, which can be achieved through a combination of improving productivity and greater attention to livestock healthcare.
Veterinary diagnostics is yet another segment that is expanding rapidly. Increased diagnostic testing to track an animal’s health trends over time and detect potential symptoms before they worsen is being driven by trends toward greater ‘wellness care,’ particularly in pets.

Manufacturers are focusing on public awareness as their effective market strategy

To gain a competitive advantage, major corporations have implemented a variety of business strategies, including regional expansion strategies, mergers and acquisitions, and collaborative research initiatives. Several programs and initiatives are underway to raise public awareness and education about animal health and well-being. Among the world’s leading Animal Healthcare companies are Neogen, Zoetis, Merck, Boehringer Ingelheim, Elanco, Dechra Pharmaceuticals, IDEXX Laboratories, B. Braun Vet Care, and Medtronic.

Cadila Healthcare’s (Zydus Cadila’s) wholly-owned material subsidiary Zydus Animal Health and Investments (ZAHL), sold its Animal Healthcare business for nearly INR 3,000 crore to a consortium led by Multiples Alternate Asset Management in May 2021.

Hester Biosciences announced in April 2021 that it would begin developing research-based herbal products for poultry, cattle, sheep, goats, and swine.

Some of the Key Players Operating in the \ Market Include:

Neogen, Zoetis, Merck, Boehringer Ingelheim, Elanco, Dechra Pharmaceuticals, IDEXX Laboratories, B. Braun Vet Care, and Medtronic.

More Insights Available

North America is currently the largest animal health market, owing to a high adoption rate of pets, rising pet healthcare expenditure, and an increasing focus on animal welfare. The region is expected to maintain its dominance during the forecast period.

A Old Full Report Analysis Click Here

Animal Healthcare Market Segmentation

Product Type:

Feed Additives
Pharmaceuticals
Vaccines

Animal Type:

Production Animals
Companion Animals

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Herbal Medicinal Products Market Poised for Significant Growth, Projected to Reach USD 417.99 Billion by 2033 at a 7.7% of CAGR

The global herbal medicinal products market is set for remarkable growth, with revenue totaling USD 199.07 billion in 2023, according to a recent study by Future Market Insights (FMI). The market is expected to expand significantly, reaching an estimated USD 417.99 billion by 2033, driven by a robust compound annual growth rate (CAGR) of 7.7% during the forecast period.

According to a recent Future Industry Insights report, certain qualities have been critical in driving growth in the herbal medicinal product market. Sales of these items are expected to hit US$ 171.62 billion in 2021, with a compound annual growth rate of 7.7% forecast from 2021 to 2031.

Growing worries about the side effects of allopathic drugs have resulted in a steady shift in preference for traditional herbal treatments. These treatments are frequently used to cure a variety of maladies, including as neurological diseases, coughs, colds, and flu, sexual troubles, feminine concerns, and metabolic diseases. Herbal medicine is valued for its potential to enhance health and systemic balance without drowsiness or negative side effects.

In 2015, Brazil’s La Politica Integral de Atención Integral a la Salud Indigena de FUNASA supported indigenous communities’ traditional health systems, while the government recognized homeopathic medicines as a medical specialty and incorporated them in the National Health System. Brazil today has approximately 12,000 homeopathic doctors and 300 homeopathic chemists.

According to the World Health Organisation (WHO), herbal medicines are used by approximately 60% of the world’s population for primary healthcare, with this figure rising to up to 80% in underdeveloped countries. Around 75% of these sales are done through direct user-pharmacy contacts. The growth of online pharmacies and mail-order shopping has boosted demand for self-medication even further.

The global geriatric population is growing rapidly due to higher life expectancy rates. The World Bank reports that in 1990, the average mortality rate among the elderly worldwide was around 6%, rising to 9.5% in 2020. Chronic diseases associated with aging populations highlight the need for effective medications.

Key Takeaways from Herbal Medicinal Products Study:

Demand for Chinese medications is expected to grow at an 8.2% CAGR through 2031, owing to investments in the promotion of traditional Chinese medicine.
By 2031, retail pharmacies will account for more than 23% of the global market. This is owing to the ease of access to consumer health products.
The most profitable market for herbal medicinal goods is Europe, with Germany accounting for around 18% of the regional market in 2031.
China is the East Asian market leader, accounting for more than 49% of the market in 2031.
In 2031, South Asia will be the third most profitable market, with India accounting for more than 74% of the market.

Competitive Landscape

Herbal medicine manufacturers are primarily interested in strategic expansions and patent filings to consolidate growth in a competitive industry.

For example, Arkopharma SA filed a patent in October 2020 for the Arkodigest® No Reflux 100% natural composition to enhance digestion.

Mountain Rose Herbs plans to turn the Phoenix Industrial Park in Eugene, which has 205,000 square feet of operational space and a 12-acre campus, into green space in November 2020 as part of its corporate expansion strategy.

The key market players covered by FMI include:

Blackmores Limited,
Sanofi-Aventis Healthcare PTY Ltd.,
Arkopharma SA,
Nutraceutical Corporation,
STADA Arzneimittel AG,
Himalaya Global Holdings Ltd,
Integria Healthcare,
Boiron Group,
Young Living Essential Oils,
Mountain Rose Herbs

A Old Full Report Analysis Click Here

Herbal Medicinal Products Market by Category

Product Type:

Ayurvedic
Homeopathic Medicines
Chinese Medicines
Aromatherapy product

Form:

Capsules/Tablets
Powder
Syrups
Oil and ointment
Others

Distribution Channel:

Hospital pharmacies
Retail pharmacies
Mail order pharmacies
E commerce

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube